Understanding Alzheimer's Disease Biomarkers at the University of Kentucky

Core F: University of Kentucky Alzheimer's Disease Core Center

NIH-funded research University of Kentucky · NIH-11123391

This project aims to find different biological signs in people to better understand how Alzheimer's disease and other dementias develop.

Quick facts

Grant typeP30 center grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky NIH-funded
Lab location1 site (Lexington, United States)
Project IDNIH-11123391 on NIH RePORTER

What this research studies

This core focuses on identifying various biological markers (biomarkers) that show how different underlying issues contribute to memory decline. We collect blood and spinal fluid samples to look for signs of Alzheimer's, blood vessel problems, and inflammation. We also use advanced MRI scans to see changes in the brain and explore wearable devices to track sleep and activity patterns. This multi-faceted approach helps us gain new insights into complex dementias, especially those with multiple causes. Our goal is to characterize individuals from a cognitively normal state through their cognitive transitions.

Who could benefit from this research

Good fit: Individuals experiencing cognitive changes or those at risk for Alzheimer's disease and other dementias, including those who are cognitively normal but part of a cohort, would be ideal candidates.

Not a fit: Patients not interested in providing biological samples or undergoing imaging may not directly benefit from participation in this specific biomarker collection effort.

Why it matters

Potential benefit: If successful, this work could lead to earlier and more accurate ways to identify Alzheimer's disease and related dementias, potentially guiding future treatments.

How similar studies have performed: The use of multimodal biomarkers is a growing area in dementia research, with many studies showing promise in identifying disease progression and underlying pathologies.

Where this research is happening

Lexington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's Disease Core CenterAlzheimer's disease biological marker
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.